Pulmatrix, Inc. Common Stock
PULM •
Sell Open
Signal type
Sell
Status
Open
Open Price
$1.41
Stop Loss
$1.96
Performance
11.70%
Days Open
20
Signal Setup
Signal Type Sell
Status Open
Open Date Mar 26, 2026
Open Price $1.41
Stop Loss $1.96
Timespan Day
Company Profile
Name Pulmatrix, Inc. Common Stock
Ticker PULM
Market Cap $25.20M
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $1.25
List Date Mar 21, 2014
Description
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
Website Open Company Website